COVID-19 Patients on Extracorporeal Membrane Oxygenation Did Not Experience Increased Prevalence of Intracranial Hemorrhage.

Autor:	Al Shabeeb RQ; Internal Medicine Residency Program, Department of Internal Medicine, INOVA Health System, Falls Church, VA., Desai M; Internal Medicine Residency Program, Department of Internal Medicine, INOVA Health System, Falls Church, VA., Lantry JH 3rd; Internal Medicine Residency Program, Department of Internal Medicine, INOVA Health System, Falls Church, VA., Simou J; Internal Medicine Residency Program, Department of Internal Medicine, INOVA Health System, Falls Church, VA., Rosner CM; Internal Medicine Residency Program, Department of Internal Medicine, INOVA Health System, Falls Church, VA., Speir AM; Internal Medicine Residency Program, Department of Internal Medicine, INOVA Health System, Falls Church, VA., Singh R; Internal Medicine Residency Program, Department of Internal Medicine, INOVA Health System, Falls Church, VA., Moran P; Internal Medicine Residency Program, Department of Internal Medicine, INOVA Health System, Falls Church, VA., Young KD; Internal Medicine Residency Program, Department of Internal Medicine, INOVA Health System, Falls Church, VA., King CS; Internal Medicine Residency Program, Department of Internal Medicine, INOVA Health System, Falls Church, VA.
Jazyk:	angličtina
Zdroj:	Critical care medicine [Crit Care Med] 2022 Sep 01; Vol. 50 (9), pp. e722-e723. Date of Electronic Publication: 2022 Aug 15.
DOI:	10.1097/CCM.0000000000005572
Abstrakt:	Competing Interests: Dr. Singh received funding from Baxter. Dr. King received funding from Untied Therapeutics, Actelion, and Boehringer-Ingelheim Pharmaceuticals. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu